Literature DB >> 3782476

Analysis of the apolipoprotein B gene and messenger ribonucleic acid in abetalipoproteinemia.

K J Lackner, J C Monge, R E Gregg, J M Hoeg, T J Triche, S W Law, H B Brewer.   

Abstract

The apolipoprotein B-100 (apoB-100) gene in leukocytes and the apoB-100 messenger RNA (mRNA) and translated apolipoprotein in the livers from normal and abetalipoproteinemic individuals were evaluated. Four complementary DNA probes for apoB-100 covering the 5', middle, and 3' regions of the apoB-100 mRNA were utilized and Southern blot analysis indicated that the apoB-100 gene is present in abetalipoproteinemia without major insertions or deletions. Polyadenylated hepatic apoB-100 mRNA from two abetalipoproteinemic patients was normal in size, and the concentration of apoB-100 mRNA was increased sixfold compared with control hepatic apoB-100 mRNA levels. ApoB-100 was detected in hepatocytes of abetalipoproteinemic patients by immunohistochemical techniques. These results indicate that the biochemical defect in abetalipoproteinemic patients studied is most consistent with a posttranslational defect in apoB-100 processing or secretion with an up-regulation of the apoB-100 mRNA.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3782476      PMCID: PMC423946          DOI: 10.1172/JCI112766

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  21 in total

1.  Enzyme-labeled antibodies: preparation and application for the localization of antigens.

Authors:  P K Nakane; G B Pierce
Journal:  J Histochem Cytochem       Date:  1966-12       Impact factor: 2.479

2.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

Authors:  P S Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

3.  Characterization of monoclonal antibodies against human low density lipoprotein.

Authors:  R W Milne; R Theolis; R B Verdery; Y L Marcel
Journal:  Arteriosclerosis       Date:  1983 Jan-Feb

4.  Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia.

Authors:  D P Muller; J K Lloyd
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  The carbohydrate composition of human apo low density lipoprotein from normal and type II hyperlipoproteinemic subjects.

Authors:  P Lee; W C Breckenridge
Journal:  Can J Biochem       Date:  1976-01

6.  The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins.

Authors:  N Swaminathan; F Aladjem
Journal:  Biochemistry       Date:  1976-04-06       Impact factor: 3.162

7.  The role of vitamin E deficiency in the abnormal autohemolysis of acanthocytosis.

Authors:  H J Kayden; R Silber; C E Kossmann
Journal:  Trans Assoc Am Physicians       Date:  1965

8.  Apolipoprotein localization and quantitation in the human intestine.

Authors:  P H Green; J H Lefkowitch; R M Glickman; J W Riley; E Quinet; C B Blum
Journal:  Gastroenterology       Date:  1982-12       Impact factor: 22.682

9.  Normotriglyceridemic abetalipoproteinemia. absence of the B-100 apolipoprotein.

Authors:  M J Malloy; J P Kane; D A Hardman; R L Hamilton; K B Dalal
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  15 in total

1.  Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice.

Authors:  M Raabe; M M Véniant; M A Sullivan; C H Zlot; J Björkegren; L B Nielsen; J S Wong; R L Hamilton; S G Young
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

2.  Homozygous hypobetalipoproteinemia: a disease distinct from abetalipoproproteinemia at the molecular level.

Authors:  R S Ross; R E Gregg; S W Law; J C Monge; S M Grant; K Higuchi; T J Triche; J Jefferson; H B Brewer
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Genetic evidence from two families that the apolipoprotein B gene is not involved in abetalipoproteinemia.

Authors:  P J Talmud; J K Lloyd; D P Muller; D R Collins; J Scott; S Humphries
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

4.  Effect of intestinal chylomicron secretory blockade on apolipoprotein synthesis in the newborn piglet.

Authors:  D D Black
Journal:  Biochem J       Date:  1992-04-01       Impact factor: 3.857

Review 5.  Diagnosis of genetic disease using recombinant DNA. Supplement.

Authors:  D N Cooper; J Schmidtke
Journal:  Hum Genet       Date:  1987-09       Impact factor: 4.132

6.  Control of Hep G2-cell triacylglycerol and apolipoprotein B synthesis and secretion by polyunsaturated non-esterified fatty acids and insulin.

Authors:  C D Byrne; T W Wang; C N Hales
Journal:  Biochem J       Date:  1992-11-15       Impact factor: 3.857

7.  Exclusion of linkage between the human apolipoprotein B gene and abetalipoproteinemia.

Authors:  L S Huang; P A Jänne; J de Graaf; M Cooper; R J Deckelbaum; H Kayden; J L Breslow; R J Decklebaum
Journal:  Am J Hum Genet       Date:  1990-06       Impact factor: 11.025

8.  Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in a nonhepatic cell line.

Authors:  R N Thrift; J Drisko; S Dueland; J D Trawick; R A Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Anderson's disease: genetic exclusion of the apolipoprotein-B gene in two families.

Authors:  M Pessah; P Benlian; I Beucler; N Loux; J Schmitz; C Junien; R Infante
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

Review 10.  Lipoproteins, cholesterol homeostasis and cardiac health.

Authors:  Tyler F Daniels; Karen M Killinger; Jennifer J Michal; Raymond W Wright; Zhihua Jiang
Journal:  Int J Biol Sci       Date:  2009-06-29       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.